The stock has more than doubled over the past 12 months, in part due to its exposure one of the biggest themes in the market at the moment - weight loss drugs like Ozempic
That statement is nonsense.......the turnaround in the price is because they are going to be cashflow and ebitda positive with a view to being pbt positive......Ozempic has nothing to do with it unless Elly Lilly is using them to market the drug in the US and that would be similar to what they do for most drugs.
The stock has more than doubled over the past 12 months, in part...
Add to My Watchlist
What is My Watchlist?
